Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer
J. Clin. Invest. Gennadi V. Glinsky, et al. 115:1503 doi:10.1172/JCI23412 [
Go to this article.]
Figure 3Sequential analytical steps used for identification, selection, and validation of the 11-gene death-from-cancer signature. The figure shows an overview of the approach used for the development and validation of a cancer survival predictor based on gene expression monitoring.
